CAR-T, iPSC, BNCT, heavy ion and proton therapy — 2D Healthcare, Türkiye representative of Japan's accredited coordinator I-Cell Networks, manages your journey with the highest discretion and care: medical visa, private interpreter, accommodation and follow-up — every detail considered for you.
Prepared in Japan from your own tumor tissue, the vaccine teaches your immune system to recognize the tumor. Low side-effect profile, outpatient application.
By your side from application to treatment: answers your questions, explains the process, shows you the way.
Hello! I'm Tudi
Your journey's guide
In Japan, international patients cannot apply directly; an accredited coordinator is mandatory. We are I-Cell Networks' exclusive representative in Türkiye.
Select your diagnosis type and see the most preferred methods from the Japan portfolio. Final eligibility always depends on the evaluation of Japanese physicians.
Japan has the world's most advanced infrastructure in cellular and particle therapies. Here are the doors we open for our patients — the full I-Cell Networks portfolio.
Cell & Gene TherapyVirus-free gene transfer — pioneered in Japan
Transposon (piggyBac) technology replaces expensive lentiviral vectors of conventional CAR-T manufacturing, lowering cost and simplifying strict GMP processes.
Stem Cell & RegenerativeNobel-winning iPSC technology — CiRA Kyoto & Takeda
The iPSC technology that earned Shinya Yamanaka the Nobel Prize became the iCART program at Kyoto University's CiRA under Dr. Shin Kaneko, then advanced globally with Takeda. Unlimited, standardized CAR-T cells from a single cell line.
Particle Beam TherapyCell-level selectivity, often a single session
A boron compound accumulates in tumor cells; a neutron beam destroys only the boron-loaded cells, sparing healthy tissue almost entirely. Japan was the first country to approve BNCT for routine clinical use in 2020.
Particle Beam TherapyQST Chiba — over 12,000 patients since 1994
Carbon ions deposit maximum energy at the tumor's depth (Bragg peak). Surgery-free, high local control in challenging tumors such as pancreas, liver, bone & soft tissue and prostate. Published series report 5-year local control above 90% in prostate cancer.
Particle Beam TherapyMillimetric precision — gold standard for children and sensitive organs
Protons leave almost no dose beyond the target. Minimizes long-term side effects in tumors near the brain and spinal cord, and in pediatric patients. University of Tsukuba PMRC is Japan's most established proton center.
ImmunotherapyA vaccine made from your own tumor tissue
Prepared from the patient's own tumor tissue, the vaccine carries all tumor antigens rather than a single one, naturally training the immune system. Aims to reduce recurrence risk after surgery.
ImmunotherapyRe-arming the immune system
NK (natural killer) cell and dendritic cell therapies multiply and strengthen the patient's own immune cells in the lab and return them. A supportive option alongside standard treatments or a new path when options run out.
ImmunotherapyHikari Clinic, Tokyo — photosensitizer + light
A light-sensitive agent given intravenously accumulates in cancer cells; light applied to the region selectively destroys only cancer cells through a photochemical reaction, then activates the body's own immune response against the tumor.
Interventional TherapyIGT Clinic, Osaka — direct to the tumor via catheter
A hair-thin catheter advanced from the groin reaches the artery feeding the tumor; medication is delivered directly to cancer cells and the feeding vessel is blocked. Combined with hyperthermia (heat therapy) and immunotherapy, the effect is amplified. A low-burden option for recurrence and metastasis.
Stem Cell & RegenerativeJapan's national hallmark — iPSC infrastructure
In early 2026, Japan made history by granting the world's first official approvals for iPSC-derived therapies (Parkinson's and heart failure). The same mature infrastructure is open to patients in orthopedic, neurological and tissue-repair stem cell applications.
SurgeryRobotic and minimally invasive approach
Robotic (da Vinci) and laparoscopic cancer surgery at Japan's reference university hospitals — experienced teams, short hospital stays and meticulous post-operative protocols. You are referred to the right center through I-Cell Networks coordination.
Stem Cell & RegenerativeSinclair Ginza Clinic, Tokyo — cell-free regenerative support
AinPros®, produced by Advalife Science, contains exosomes derived from stem cell culture and over 2,000 bioactive substances (growth factors, cytokines). Applied via IV drip or locally, it supports tissue repair, inflammation reduction and immune balance.
patients treated with heavy ions at QST since 1994
heavy ion centers in Japan — roughly half of the world's
Japan became the first country to approve BNCT for routine clinical use
5-year local control in prostate cancer with heavy ions (published series)
world's first iPSC therapy approvals were granted in Japan in 2026
cancer types addressable with photo-immunotherapy
Source: clinical data published by the centers and public institutional reports.
World's first heavy ion center — 12,000+ patients
High-precision scanning beam
Reference center of western Japan
Close to the Tokyo metro area
East Japan center
University-backed center in Kobe
Japan's apex oncology institution
Japan's most established proton center
Koriyama, Fukushima
Kagoshima — treatment & stay campus
Home of BNCT in routine clinical care
Neutron source research infrastructure
World center of iPSC research
Photo-immunotherapy & advanced immunotherapy
Incision-free catheter therapy, hyperthermia, regenerative medicine
AinPros® exosome support therapy — Ginza
Low-dose chemo, autologous cancer vaccine, cancer dormancy therapy, second opinion — Ginza
A journey through Japan's university hospitals — alongside robotic systems, particle therapy centers and personalized medicine labs.
Register on the portal and securely upload your reports and scans.
Your documents are translated into Japanese and sent to the expert board. Response within 5 business days.
You receive the suitable center, treatment plan and a clear cost offer.
Medical stay visa, flights, accommodation and transfers are arranged by us.
An interpreter accompanies every consultation; payments are secured via the coordinator.
Post-return control plan and the bridge to Japan stay with us.
Select the diagnosis; we instantly show the suitable Japanese treatments and a step-by-step timeline. No prices — the cost is finalized with a written offer after the expert board review.
Short stories from our patients' treatment journeys across different diagnoses.
"I was told I needed surgery; I got through it without a scalpel thanks to three weeks of heavy ion therapy. My interpreter was by my side every day, everything ran like clockwork."
"By my third recurrence I had little hope left. I had a single BNCT session; the next day I was sightseeing. They handled everything, including translating my reports into Japanese."
"I uploaded my reports through the portal and had the Japanese board's evaluation within five days. At every step I knew what would happen next."
"Chemo was my only remaining option for metastasis. After incision-free catheter therapy and hyperthermia we reached our targets; my follow-up continued back home."
Stories are published anonymized for privacy.
Real patients, real experiences — in their own words, on camera.
Approvals, clinical innovations and updates in our treatment portfolio.
Free preliminary evaluation within 5 business days.
Consent forms, KVKK notice and the remote service agreement. Review, download, and upload the signed copy via your portal.
Governs how your personal data (identity, contact, diagnosis, test results, imaging, treatment information) is processed within medical tourism, the conditions of transfer to healthcare institutions in Japan, and your rights (disclosure, correction, deletion, suspension of use).
Sets out in 12 articles that 2D Healthcare provides no medical services; covers intermediary services such as applications, communication, travel and accommodation organization, fee-refund terms, data transfer consent, and the parties' obligations.
2D Healthcare Magazine
The Japan Difference in Cancer Care
